GB0312844D0 - Use of compounds in medicine - Google Patents

Use of compounds in medicine

Info

Publication number
GB0312844D0
GB0312844D0 GBGB0312844.4A GB0312844A GB0312844D0 GB 0312844 D0 GB0312844 D0 GB 0312844D0 GB 0312844 A GB0312844 A GB 0312844A GB 0312844 D0 GB0312844 D0 GB 0312844D0
Authority
GB
United Kingdom
Prior art keywords
medicine
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0312844.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Paradigm Therapeutics Ltd
Original Assignee
Paradigm Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paradigm Therapeutics Ltd filed Critical Paradigm Therapeutics Ltd
Priority to GBGB0312844.4A priority Critical patent/GB0312844D0/en
Publication of GB0312844D0 publication Critical patent/GB0312844D0/en
Priority to PCT/GB2004/002301 priority patent/WO2004108141A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GBGB0312844.4A 2003-06-04 2003-06-04 Use of compounds in medicine Ceased GB0312844D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0312844.4A GB0312844D0 (en) 2003-06-04 2003-06-04 Use of compounds in medicine
PCT/GB2004/002301 WO2004108141A2 (en) 2003-06-04 2004-06-01 Bach-o-protein coupled receptor releated methods

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0312844.4A GB0312844D0 (en) 2003-06-04 2003-06-04 Use of compounds in medicine

Publications (1)

Publication Number Publication Date
GB0312844D0 true GB0312844D0 (en) 2003-07-09

Family

ID=9959315

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0312844.4A Ceased GB0312844D0 (en) 2003-06-04 2003-06-04 Use of compounds in medicine

Country Status (2)

Country Link
GB (1) GB0312844D0 (en)
WO (1) WO2004108141A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100284984A1 (en) * 2007-07-30 2010-11-11 University Of Rochester Adenosine and its mimetics. modulators, transport inhibitors, and receptor agonists as a therapeutic tool to replace or improve the efficacy of deep brain stimulation
ITTO20110576A1 (en) * 2011-06-30 2012-12-31 Medicam Health Science S R L COMPOSITION INCLUDING THE ASSOCIATION OF MELISSA PHYTO-EXTRACT, METHYLAMIDE AND A SOURCE OF NUCLEOTIDES AND / OR NUCLEOSIDES AND ITS USE IN THE TREATMENT OF HEADACHE AND HEMICRYANES
WO2019204392A1 (en) * 2018-04-17 2019-10-24 Purdue Research Foundation Modifying surface of a live cell and the uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5547942A (en) * 1994-01-04 1996-08-20 Rapaport; Eliezer Method of treatment of diabetes mellitus by administration of adenosine 5'-t
US6440455B1 (en) * 1997-09-02 2002-08-27 Children's Medical Center Corporation Methods for modulating the axonal outgrowth of central nervous system neurons
AU2100901A (en) * 1999-12-15 2001-06-25 Bruce H. Levin Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
AU2603101A (en) * 1999-12-22 2001-07-03 Inspire Pharmaceuticals, Inc. Method of treating gastrointestinal tract disease with purinergic receptor agonists
AU1252102A (en) * 2000-11-07 2002-05-21 Paradigm Therapeutics Ltd Receptor
US6946244B2 (en) * 2001-08-07 2005-09-20 Euroscreen, S.A. Methods of identifying a ligand, an agonist, and an antagonist of G protein coupled receptor GPR86 (P2Y13)
US20030059857A1 (en) * 2001-09-17 2003-03-27 Schering Corporation G-protein coupled receptor and methods

Also Published As

Publication number Publication date
WO2004108141A2 (en) 2004-12-16
WO2004108141A3 (en) 2005-03-31

Similar Documents

Publication Publication Date Title
GB0324761D0 (en) Use of compounds in therapy
IL176248A0 (en) N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
GB0307918D0 (en) Therapeutic use
IL172316A0 (en) Novel compounds and their use in therapy
EP1682136A4 (en) Therapeutic compounds and uses thereof
GB0305150D0 (en) Use of therapeutic compounds
GB0306604D0 (en) Second medical use
GB0300804D0 (en) Compounds and their use
GB0300805D0 (en) Compounds and their use
GB0312844D0 (en) Use of compounds in medicine
GB0301143D0 (en) Compounds and their use
GB0312845D0 (en) Use of componds in medicine
GB0317133D0 (en) Compounds and their use
GB0322195D0 (en) Compounds and their medical uses
GB0322194D0 (en) Compounds and their medical uses
GB0322990D0 (en) Therapeutic use
GB0304820D0 (en) Compounds and their use
GB0314293D0 (en) Compounds and their use
GB0311820D0 (en) Compounds and their use
GB0301146D0 (en) Compounds and their use
GB0314295D0 (en) Compounds and their use
GB0321442D0 (en) Compounds and their use
GB0321301D0 (en) Compounds and their use
GB0320064D0 (en) Compounds and their use
GB0301147D0 (en) Compounds and their use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)